publication . Article . 2016

HER2 status and disparities in luminal breast cancers

Holowatyj, Andreana N.; Ruterbusch, Julie J.; Ratnam, Manohar; Gorski, David H.; Cote, Michele L.;
  • Published: 01 Jun 2016
  • Publisher: Wiley
Abstract
Abstract National Comprehensive Care Network guidelines for adjuvant treatment of invasive breast cancer are based on HER2 and hormone receptor (HR) status, where HR+ disease encompasses all estrogen receptor (ER)+ and/or progesterone receptor (PR)+ tumors. We sought to explore clinical and demographic differences among patients with HR+ breast cancer subtypes, and the role of HER2 status, age, race/ethnicity, and socioeconomic status (SES) in disease risk. We evaluated breast cancer subtype distribution, defined by HR and HER2 status, using patient clinical, demographic, and socioeconomic characteristics. Differences in HR categories by demographic and tumor ch...
Subjects
Medical Subject Headings: skin and connective tissue diseases
free text keywords: Estrogen receptor, Breast cancer, medicine.disease, medicine, Disease, Hormone receptor, Gynecology, medicine.medical_specialty, Odds ratio, Progesterone receptor, Oncology, business.industry, business, Internal medicine, Confidence interval, Socioeconomic status, Original Research, Cancer Prevention, disparities, HER2, luminal, SEER
Related Organizations
Funded by
NIH| Cancer Center Support Grant
Project
  • Funder: National Institutes of Health (NIH)
  • Project Code: 3P30CA022453-37S2
  • Funding stream: NATIONAL CANCER INSTITUTE
27 references, page 1 of 2

1 Siegel, R. L., K. D.Miller, and A.Jemal. 2016 Cancer statistics, 2016. CA Cancer J. Clin.66:7–30.26742998 [PubMed]

2 National Comprehensive Care Network . 2015 Breast cancer. NCCN Clinical Practice Guidelines in Oncology.

3 Perou, C. M., A. L.Borresen‐Dale. 2011 Systems biology and genomics of breast cancer. Cold Spring Harb. Perspect. Biol.3:a003293.21047916 [OpenAIRE] [PubMed]

4 Voduc, K. D., M. C.Cheang, S.Tyldesley, K.Gelmon, T. O.Nielsen, and H.Kennecke. 2010 Breast cancer subtypes and the risk of local and regional relapse. J. Clin. Oncol.28:1684–1691.20194857 [PubMed]

5 Rastelli, F., and S.Crispino. 2008 Factors predictive of response to hormone therapy in breast cancer. Tumori 94:370–383.18705406 [PubMed]

6 Howlader, N., S. F.Altekruse, C. I.Li, V. W.Chen, C. A.Clarke, L. A.Ries, et al. 2014 US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. J. Natl. Cancer Inst.106:dju055. doi: 10.1093/jnci/dju055.24777111 [OpenAIRE] [PubMed]

7 Akinyemiju, T. F., M.Pisu, J. W.Waterbor, and S. F.Altekruse. 2015 Socioeconomic status and incidence of breast cancer by hormone receptor subtype. Springerplus 4:508.26405628 [OpenAIRE] [PubMed]

8 Palmer, J. R., E.Viscidi, M. A.Troester, C. C.Hong, P.Schedin, T. N.Bethea, et al. 2014 Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER Consortium. J. Natl. Cancer Inst.106:dju237. doi: 10.1093/jnci/dju237.25224496 [OpenAIRE] [PubMed]

9 Heck, K. E., and E. R.Pamuk. 1997 Explaining the relation between education and postmenopausal breast cancer. Am. J. Epidemiol.145:366–372.9054241 [PubMed]

10 Kish, J. K., M.Yu, A.Percy‐Laurry, and S. F.Altekruse. 2014 Racial and ethnic disparities in cancer survival by neighborhood socioeconomic status in surveillance, epidemiology, and end results (SEER) registries. J. Natl. Cancer Inst. Monogr.2014:236–243.25417237 [OpenAIRE] [PubMed]

11 Andaya, A. A., L.Enewold, M. J.Horner, I.Jatoi, C. D.Shriver, and K.Zhu. 2012 Socioeconomic disparities and breast cancer hormone receptor status. Cancer Causes Control 23:951–958.22527173 [PubMed]

12 Dunn, B. K., T.Agurs‐Collins, D.Browne, R.Lubet, and K. A.Johnson. 2010 Health disparities in breast cancer: biology meets socioeconomic status. Breast Cancer Res. Treat.121:281–292.20437200 [PubMed]

13 Sineshaw, H. M., M.Gaudet, E. M.Ward, W. D.Flanders, C.Desantis, C. C.Lin, et al. 2014 Association of race/ethnicity, socioeconomic status, and breast cancer subtypes in the National Cancer Data Base (2010‐2011). Breast Cancer Res. Treat.145:753–763.24794028 [PubMed]

14 Howlader, N., M.Krapcho, J.Garshell, D.Miller, S. F.Altekruse, C. L.Kosary, et al., eds. 2015 SEER cancer statistics review 1975–2012. National Cancer Institute, Bethesda, MD Available at: http://seer.cancer.gov/csr/1975_2012/. Based on November 2014 SEER data submission, posted to the SEER web site, April 2015.

15 Surveillance Epidemiology and End Results (SEER) Program (www.seer.cancer.gov). SEER*Stat Database: Incidence ‐ SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2014 Sub (1973‐2012 varying) ‐ Linked To County Attributes ‐ Total U.S., 1969‐2011 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch. released April 2015, based on the November 2014 submission.

27 references, page 1 of 2
Powered by OpenAIRE Research Graph
Any information missing or wrong?Report an Issue